Vertaling van "only a few months " (Nederlands → Frans) :

Vaccines and Diagnostics: USD 2.4 billion (+38%, +39% lc) A rapid response after the outbreak of the A (H1N1) pandemic in April 2009 enabled Vaccines and Diagnostics to deliver more than 100 million vaccine doses to governments around the world in only a few months, providing USD 1.0 billion of net sales from pandemic vaccines and adjuvants in 2009.
Vaccins et Diagnostic: USD 2,4 milliards (+38%, +39% en m. l). Réagissant rapidement au déclenchement de la pandémie de grippe A(H1N1) en avril 2009, Vaccins et Diagnostic a livré, en quelque mois seulement, plus de 100 millions de doses de vaccins aux gouvernements du monde entier, fournissant ainsi pour USD 1,0 milliard de chiffre d’affaires net provenant de vaccins pandémiques et d’adjuvants en 2009.

In Europe, where Menveo is predominantly a travel vaccine, the first positive policy recommendations were received within a few months of approval.
En Europe, où Menveo est avant tout un vaccin de voyages, les autorités ont émis les premières recommandations favorables concernant la vaccination dans les mois qui ont suivi son homologation.

Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR bupropion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.
Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR Buproprion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.

A few years later, he discovered that a new medicine could treat him – if only he could afford it.
Quelques années plus tard, il découvre qu’un nouveau médicament peut le soigner – à condition de pouvoir se l’offrir.

Net sales in the top six emerging markets rose 16% lc to USD 2.8 billion in the first nine months of 2009, with only limited signs to date of adverse impact from global economic conditions.
Au cours des neuf premiers mois de 2009, le chiffre d’affaires net des six principaux marchés émergents a augmenté de 16% en m. l. à USD 2,8 milliards. A ce jour, les signes d’un impact des conditions économiques mondiales sont encore limités.